Private Equity Other Private Equity/Strategic Investments
Cancer drugs maker Immuneel Therapeutics raises Rs.100-Cr from UAE pharma co.
Source YourStory (opens in a new tab)Entrackr (opens in a new tab)
Bengaluru-based biotech startup Immuneel Therapeutics has raised INR 100 crore from Taiba Middle East FZ LLC in an extended Series A round.The firm has been valued at around INR 587 crore (USD 71 million) post-allotment. Following the fresh proceeds, Taiba Middle East FZ holds a 17% stake in Immuneel Therapeutics.Founded by Kiran Mazumdar Shaw, Siddhartha Mukherjee and Kush Parwar, Immuneel Therapeutics is engaged in developing cell and gene therapies for cancer patients.
Company website ↗ (opens in a new tab)
Between Jan 2022 and Apr 2022, Immuneel Therapeutics had raised over USD 27 M from Khosla Ventures, TrueNorth, Eight Roads Ventures and Others